See also this year's filing and all EDGAR filings for this company.
PDF Report 0001366541_2015_Q_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001366541, Q Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 721,743 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 26,568 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 1,044,163 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 3,160 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,041,705 |
| 9 | ResearchAndDevelopmentExpense | 1,973,924 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 26,175 |
| 12 | remainder_NetIncome | -70,563 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 748,311 |
| 1 | Liabilities | 1,044,163 |
| 2 | Expenses | 4,018,789 |
| 3 | Revenues | 26,175 |
| 4 | StockholdersEquity | -295,852 |
| 5 | NetIncome | -4,063,177 |
| 6 | ComprehensiveNetIncome | -4,063,177 |
| 7 | BaseVar | 2,954,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -5.25 |
| 9 | EconomicCapitalRatio | 0.155 |
Edgar->Model Mapping
Feature Distribution
Change over Time
